BE PHARMACEUTICALS AG is voluntarily recalling 22,176 vials of Fosaprepitant (Fosaprepitant for Injection) 150 mg per vial due to a lack of sterility assurance. A failure in the manufacturing process simulation indicates that the sterile environment used to produce the drug may have been compromised. No incidents or injuries have been reported to date. This medication is a sterile powder used intravenously to prevent nausea and vomiting caused by chemotherapy.
Administering a medication that is not sterile can lead to serious, life-threatening systemic infections. Patients receiving this drug are often undergoing chemotherapy and may have weakened immune systems, making them especially vulnerable to infections.
Recall #: D-0262-2024; Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.